Xcout Intel
Nostics
Nostics is a biotechnology research and diagnostic services company headquartered in Amsterdam, Netherlands. The company focuses on developing accessible diagnostic solutions.
Subscribe to see Nostics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Nostics at a glance
Nostics is a healthtech company headquartered in Netherlands. Its most recent funding round raised $350,000 in May 2020. Xcout tracks 4 named people at Nostics, including Jeroen Nieuwenhuis (CEO).
Nostics leadership
- Jeroen NieuwenhuisCEO
- Bob De VosBob De Vos
- Rochelle NiemeijerCo-founder
- Robin PatelAdvisor
Nostics funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | $350,000 | 7 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Nostics competitors
A few of Nostics's closest competitors — see the full list of competitors and alternatives →
Cradle is a private biotechnology company founded in 2021, specializing in artificial intelligence. The company operates its own wet lab in Amsterdam to develop reliable and high-performing models.
Adnexus Biotechnologies is a drug discovery and biotechnology company headquartered in Texas that focuses on delivering accessible and affordable therapeutic solutions.
NovelStem International Corp. concentrates its efforts on pioneering and introducing diagnostic solutions for cancer treatment, specifically with the goal of mitigating chemotherapy resistance. The company, which commenced operations in 1993, was previously recognized as Hollywood Media Corp. before adopting its current name in September of 2018. Its corporate headquarters are situated in Boca Raton, Florida.
Cambridge Technologies is an animal health company that provides veterinary diagnostic services and custom autogenous vaccines for bovine, swine, small ruminant, and poultry industries. Using next-generation diagnostics and specialized manufacturing, the company helps veterinarians identify pathogens and produce herd-specific vaccines to manage animal diseases.
Nanostics develops precision health technologies, specifically offering an AI-powered platform called ClarityDX. Its primary product, ClarityDX Prostate, uses clinical data and blood-based biomarkers to assess a patient's risk of aggressive prostate cancer, helping patients and healthcare providers make informed screening and testing decisions.
Get Nostics's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Nostics in Xcout Intel
- 4 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access